MAS vs SYRE · P/E 18, rev $7.56B vs $7.60B cap
Masco Corporation (MAS) versus Spyre Therapeutics Inc. (SYRE) — a side-by-side from cached financials, not a winner call.
Masco Corporation (MAS) is a building products & equipment company listed on US.
Spyre Therapeutics Inc. (SYRE) is a biotechnology company listed on NASDAQ.
Latest reported MAS revenue for 2025-12-31 was $7.56B. Net income was $810.0M. Revenue was down 3.4% from 2024-12-31 to 2025-12-31. MAS currently screens at market cap $14.00B and trailing P/E 18.1.
Latest reported SYRE revenue for 2025-12-31 was $0. Net income was -$155.2M. SYRE currently screens at market cap $7.60B.
MAS currently screens at market cap $14.00B and trailing P/E 18.1. SYRE currently screens at market cap $7.60B.
Not investment advice. Open the MAS and SYRE stock pages for the full models.
Not investment advice.